Citius Pharmaceuticals
CTXR
#10935
Rank
NZ$19.42 M
Marketcap
NZ$0.71
Share price
8.79%
Change (1 day)
-74.83%
Change (1 year)

Earnings for Citius Pharmaceuticals (CTXR)

Earnings in 2026 (TTM): -NZ$0.11 Billion

According to Citius Pharmaceuticals 's latest financial reports the company's current earnings are NZ$7.1 Million. In 2025 the company made an earning of -NZ$66.3 Million, an increase over its 2024 earnings that were of -NZ$69.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Citius Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.11 Billion52.07%
2025 -NZ$66.3 Million-4.99%
2024 -NZ$69.78 Million5.78%
2023 -NZ$65.97 Million37.8%
2022 -NZ$47.87 Million13.08%
2021 -NZ$42.34 Million12.91%
2020 -NZ$37.49 Million33.5%
2019 -NZ$28.09 Million21.61%
2018 -NZ$23.1 Million14.93%
2017 -NZ$20.1 Million23.83%
2016 -NZ$16.23 Million180.39%
2015 -NZ$5.79 Million
2013 -NZ$0.99 Million2605.74%
2012 -NZ$0.04 Million4.81%
2011 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.28 Billion 169.31%๐Ÿ‡บ๐Ÿ‡ธ USA